16954

    0

    VILINBIO

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    VILIN BIO MED LIMITED Share Price Today

    VILIN BIO MED LIMITED is currently trading at ₹42.6, up by ₹0.0 from the previous close. The stock touched an intraday high of ₹42.60 and a low of ₹38.65 during the latest trading session. Over the past one year, VILIN BIO MED LIMITED has delivered a return of 70.4%, while the stock has gained 6.36% in the last one month.

    VILIN BIO MED LIMITED performance

    Today’s low Today’s high
    ₹ 38.65 ₹ 42.60
    ₹ 42.60
    52 week low 52 week high
    ₹ 18.95 ₹ 54.40
    ₹ 42.60
    Open Price ₹ 38.65
    Prev. Close ₹ 42.60
    Volume (Shares) 8000.00
    Total traded value ₹ 3.40
    Upper Circuit ₹ 44.70
    Lower Circuit ₹ 40.50
    info

    Investment Returns

    Over 1 Month 6.36% Over 3 Months 13.90% Over 6 Months 40.59% Over 1 Year 70.40%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    VILIN BIO MED LIMITED fundamentals


    • Market cap (Cr) 65.00
    • P/E Ratio (TTM) 33.81
    • Beta 0.11
    • Book Value / share 18.60
    • Return on equity 0.96%
    • EPS (TTM) 1.26
    • Dividend yield 0.00%
    • Net profit/quarter (Cr) -0.04
    info icon alternate text
    • Market cap (Cr) [-]
    • P/E Ratio (TTM) [-]
    • Beta [-]
    • Book Value / share [-]
    • Return on equity [-]%
    • EPS (TTM) [-]
    • Dividend yield 0.00%
    • Net profit/quarter (Cr) [-]
    info icon alternate text

    VILIN BIO MED LIMITED Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2023 (Values in Cr)
    Revenue 3.30
    Operating Expense 0.00
    Net Profit -0.04
    Net Profit Margin (%) -1.21
    Earnings Per Share (EPS) 0.00
    EBITDA 0.00
    Effective Tax Rate (%) 0.00
    Particulars DEC 2022 (Values in Cr)
    Revenue 4.91
    Operating Expense 0.00
    Net Profit 0.73
    Net Profit Margin (%) 14.86
    Earnings Per Share (EPS) 2.21
    EBITDA 0.00
    Effective Tax Rate (%) 0.00
    Particulars MAR 2026 (Values in Cr)
    Revenue 42.26
    Operating Expense 39.42
    Net Profit 1.93
    Net Profit Margin (%) 4.56
    Earnings Per Share (EPS) 1.37
    EBITDA 3.18
    Effective Tax Rate (%) 32.04
    Particulars MAR 2025 (Values in Cr)
    Revenue 14.81
    Operating Expense 14.98
    Net Profit 0.22
    Net Profit Margin (%) 1.48
    Earnings Per Share (EPS) 0.16
    EBITDA 1.26
    Effective Tax Rate (%) 25.80
    Particulars MAR 2024 (Values in Cr)
    Revenue 15.80
    Operating Expense 15.91
    Net Profit 0.16
    Net Profit Margin (%) 1.01
    Earnings Per Share (EPS) 0.12
    EBITDA 1.15
    Effective Tax Rate (%) 26.08
    Particulars MAR 2023 (Values in Cr)
    Revenue 12.31
    Operating Expense 10.56
    Net Profit 1.25
    Net Profit Margin (%) 10.15
    Earnings Per Share (EPS) 1.25
    EBITDA 2.60
    Effective Tax Rate (%) 30.33
    Particulars MAR 2022 (Values in Cr)
    Revenue 11.21
    Operating Expense 11.18
    Net Profit 0.03
    Net Profit Margin (%) 0.26
    Earnings Per Share (EPS) 0.10
    EBITDA 0.77
    Effective Tax Rate (%) 25.00
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 16.53
    ROE % 0.96
    ROCE % 4.16
    Total Debt to Total Equity 0.20
    EBITDA Margin 8.51
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 16.37
    ROE % 0.95
    ROCE % 4.46
    Total Debt to Total Equity 0.35
    EBITDA Margin 7.28
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 10.73
    ROE % 13.83
    ROCE % 17.24
    Total Debt to Total Equity 0.57
    EBITDA Margin 21.12
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 22.41
    ROE % 0.41
    ROCE % 4.30
    Total Debt to Total Equity 0.73
    EBITDA Margin 6.87
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 22.31
    ROE % 1.64
    ROCE % 4.87
    Total Debt to Total Equity 0.69
    EBITDA Margin 7.34
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 0.05
    Total Assets 27.72
    Total Liabilities 27.72
    Total Equity 23.06
    Share Outstanding 1
    Price to Book Ratio 1.23
    Return on Assets (%) 0.80
    Return on Capital (%) 0.87
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 6.04
    Total Assets 32.40
    Total Liabilities 32.40
    Total Equity 22.84
    Share Outstanding 1
    Price to Book Ratio 1.16
    Return on Assets (%) 0.50
    Return on Capital (%) 0.55
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 0.03
    Total Assets 17.67
    Total Liabilities 17.67
    Total Equity 10.67
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 7.04
    Return on Capital (%) 7.98
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 0.03
    Total Assets 13.55
    Total Liabilities 13.55
    Total Equity 7.39
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 0.24
    Return on Capital (%) 0.26
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 0.04
    Total Assets 13.89
    Total Liabilities 13.89
    Total Equity 7.36
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 0.87
    Return on Capital (%) 0.94
    Particulars MAR 2025 (Values in Cr)
    Net Income 0.30
    Cash from Operations 0.75
    Cash from Investing -1.10
    Cash from Financing -5.10
    Net change in Cash -5.99
    Free Cash Flow 2.32
    Particulars MAR 2024 (Values in Cr)
    Net Income 0.22
    Cash from Operations -7.04
    Cash from Investing 0.32
    Cash from Financing 8.87
    Net change in Cash 1.77
    Free Cash Flow -7.04
    Particulars MAR 2023 (Values in Cr)
    Net Income 1.78
    Cash from Operations -1.12
    Cash from Investing -0.02
    Cash from Financing 1.68
    Net change in Cash 0.00
    Free Cash Flow -1.09
    Particulars MAR 2022 (Values in Cr)
    Net Income 0.04
    Cash from Operations 0.21
    Cash from Investing 0.00
    Cash from Financing -0.21
    Net change in Cash 0.00
    Free Cash Flow 0.21
    Particulars MAR 2021 (Values in Cr)
    Net Income 0.16
    Cash from Operations -0.96
    Cash from Investing 0.00
    Cash from Financing 0.98
    Net change in Cash -0.02
    Free Cash Flow -0.96
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 31.80 13.20 1.53 243.69 23.12 38.85
    BLISS GVS PHARMA LTD 461.00 37.06 4.09 4889.19 118.35 552.90
    CIPLA LTD. 1409.85 31.83 3.30 113894.07 1165.55 1672.20
    FERMENTA BIOTECH LTD. 444.00 20.77 3.21 1306.74 256.40 480.00
    GLAXOSMITHKLINE PHARMA LT 2550.20 44.90 19.05 43201.93 2088.00 3202.80
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 31.80 22.24 4.09 243.69 23.12 38.85
    AMRUTANJAN HEALTH CARE LTD. 513.60 23.02 4.01 1484.85 490.00 789.95
    ASTRAZENECA PHARMA INDIA LTD. 8167.90 106.74 23.39 20419.75 7630.00 9850.00
    BLISS GVS PHARMA LTD 461.00 49.84 4.23 4889.19 118.35 552.90

    VILIN BIO MED LIMITED shareholding pattern

    Holding
    43.35%
    56.64%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    VILIN BIO MED LIMITED Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    42.60 0.00 redarrow
    red-green-graph indicator
    14 Bearish
    2 Bullish
    • 5 Days 42.80
    • 26 Days 44.40
    • 10 Days 43.60
    • 50 Days 43.50
    • 12 Days 43.80
    • 100 Days 40.00
    • 20 Days 44.30
    • 200 Days 35.00
    41.28 PIVOT
    First Support 39.97 First Resistance 43.92 Second Support 37.33 Second Resistance 45.23 Third Support 36.02 Third Resistance 47.87
    RSI 45.37 ADX 6.73 MACD -0.59 Williams % R -62.02 Commodity Channel Index (CCI) -106.65
    Date 2026-07-27 Week 14000.00 Same Day 8000.00 Month 14750.00
    1 Year 0.12 3 Year 0.22
    Over 1 Month
    6.36% down
    Over 1 Year
    70.40% down
    Over 3 Months
    13.90% down
    Over 3 Years
    20.66% down
    Over 6 Months
    40.59% down
    Over 5 Years
    0.00% down

    VILIN BIO MED LIMITED Corporate Actions

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Vilin Bio Med Ltd?

    Answer Field

    Vilin Bio Med Ltd share price is for NSE ₹ 42.60 & for BSE ₹ 0.00 as on Jul 27 2026 02:57 PM.

    What is the Market Cap of Vilin Bio Med Ltd Share?

    Answer Field

    The market cap of Vilin Bio Med Ltd for NSE ₹ 65.00 & for BSE ₹ 0.00 as on Jul 27 2026 02:57 PM.

    What is the 52 Week High and Low of Vilin Bio Med Ltd?

    Answer Field

    The 52 Week High and Low of Vilin Bio Med Ltd for NSE is ₹ 54.40 and ₹ 18.95 and for BSE is ₹ 0.00 and ₹ 0.00.

    What is 1 year return for Vilin Bio Med Ltd?

    Answer Field

    The 1 year returns on the stock has been 70.40%.

    What is the P/E Ratio of Vilin Bio Med Ltd Share?

    Answer Field

    As on Jul 27 2026 02:57 PM the price-to-earnings (PE) ratio for Vilin Bio Med Ltd share is 33.81.

    What is the PB ratio of Vilin Bio Med Ltd Share?

    Answer Field

    As on Jul 27 2026 02:57 PM, the price-to-book (PB) ratio for Vilin Bio Med Ltd share is 18.60.

    How to Buy Vilin Bio Med Ltd Share?

    Answer Field

    You can trade in Vilin Bio Med Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Vilin Bio Med Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Vilin Bio Med Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Vilin Bio Med Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |